Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Paul J Bröckelmann; Boris Böll; Daniel Molin; Gundolf Schneider; Sirpa Leppä; Julia Meissner; Peter Kamper; Martin Hutchings; Jacob H Christensen; Ulf Schnetzke; Michael Fuchs; Janina Jablonski; Dennis A Eichenauer; Bastian von Tresckow; Wolfram Klapper; Carsten Kobe; Peter Borchmann; Alexander Fosså

doi:10.1002/hem3.70190

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Paul J Bröckelmann^*, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob H Christensen, Ulf Schnetzke, Michael Fuchs, Janina Jablonski, Dennis A Eichenauer, Bastian von Tresckow, Wolfram Klapper, Carsten Kobe, Peter Borchmann, Alexander Fosså

^*Corresponding author af dette arbejde

Afdeling for Blodsygdomme CKO

1 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	e70190
Tidsskrift	HemaSphere
Vol/bind	9
Udgave nummer	8
ISSN	2572-9241
DOI	https://doi.org/10.1002/hem3.70190
Status	Udgivet - aug. 2025

Adgang til dokumentet

10.1002/hem3.70190Licens: CC BY-NC-ND

Andre filer og links

Link to publication in Scopus

Citationsformater

Bröckelmann, P. J., Böll, B., Molin, D., Schneider, G., Leppä, S., Meissner, J., Kamper, P., Hutchings, M., Christensen, J. H., Schnetzke, U., Fuchs, M., Jablonski, J., Eichenauer, D. A., von Tresckow, B., Klapper, W., Kobe, C., Borchmann, P., & Fosså, A. (2025). Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients. HemaSphere, 9(8), Artikel e70190. https://doi.org/10.1002/hem3.70190

Bröckelmann, PJ, Böll, B, Molin, D, Schneider, G, Leppä, S, Meissner, J, Kamper, P, Hutchings, M, Christensen, JH, Schnetzke, U, Fuchs, M, Jablonski, J, Eichenauer, DA, von Tresckow, B, Klapper, W, Kobe, C, Borchmann, P & Fosså, A 2025, 'Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients', HemaSphere, bind 9, nr. 8, e70190. https://doi.org/10.1002/hem3.70190

@article{332abdb16abd4525a30637dc8001c71f,

title = "Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients",

author = "Br{\"o}ckelmann, {Paul J} and Boris B{\"o}ll and Daniel Molin and Gundolf Schneider and Sirpa Lepp{\"a} and Julia Meissner and Peter Kamper and Martin Hutchings and Christensen, {Jacob H} and Ulf Schnetzke and Michael Fuchs and Janina Jablonski and Eichenauer, {Dennis A} and {von Tresckow}, Bastian and Wolfram Klapper and Carsten Kobe and Peter Borchmann and Alexander Foss{\aa}",

year = "2025",

month = aug,

doi = "10.1002/hem3.70190",

language = "English",

volume = "9",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

AU - Bröckelmann, Paul J

AU - Böll, Boris

AU - Molin, Daniel

AU - Schneider, Gundolf

AU - Leppä, Sirpa

AU - Meissner, Julia

AU - Kamper, Peter

AU - Hutchings, Martin

AU - Christensen, Jacob H

AU - Schnetzke, Ulf

AU - Fuchs, Michael

AU - Jablonski, Janina

AU - Eichenauer, Dennis A

AU - von Tresckow, Bastian

AU - Klapper, Wolfram

AU - Kobe, Carsten

AU - Borchmann, Peter

AU - Fosså, Alexander

PY - 2025/8

Y1 - 2025/8

UR - http://www.scopus.com/inward/record.url?scp=105013507428&partnerID=8YFLogxK

U2 - 10.1002/hem3.70190

DO - 10.1002/hem3.70190

M3 - Letter

C2 - 40832013

SN - 2572-9241

VL - 9

JO - HemaSphere

JF - HemaSphere

IS - 8

M1 - e70190

ER -